All News

From “Sex and the City” star and “real-life Tarzan” dying to a man planning to swim the English Channel to raise cancer funds, here is what is happening in the cancer space this week.

The antibody drug conjugate could provide patients with symptomatic relief, along with manageable side effects.

The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.

Children younger than five years old may have an increased risk for hearing loss from cisplatin-based therapies compared with older children, highlighting the potential need for more consistent monitoring for hearing loss in children with cancer.

A cancer survivor shares six helpful tips for getting through the difficulties of cancer treatment.

Where do you turn when your child is diagnosed with a rare cancer? In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares the harrowing experience of learning their nine-year-old had neuroendocrine cancer.

Patients who are living with MPN should live a healthy lifestyle and not compare their disease to others, because of variability between mutations, according to an expert.

The tome also reflects on his own diagnosis of cancer and how it influenced his practice.

The FDA has granted approval to Jakafi (ruxolitinib) for the treatment of chronic graft-versus-host disease (GVHD).

The process of scheduling and receiving scans to monitor your disease can be emotionally triggering and traumatic as a patient with cancer, one woman explains.

The FDA approval of Cabometyx was based on results that showed that the drug was associated with improved outcomes in patients with radioactive iodine–refractory locally advanced or metastatic differentiated thyroid cancer.

The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.

Knowledge and open communication are key to creating a competent cancer care team and ensuring better outcomes.

Sierra Oncology completed enrollment for its phase 3 MOMENTUM clinical trial for the treatment of patients with myelofibrosis.

The CURE® Poetry Contest winners explain what inspired each of their poems, from the death of a friend and oncologist who treated one survivor’s cancer to the emotional experience of losing hair during treatment.

Coronary artery disease was far more common in young women with breast cancer who had radiation to their left breast than in those who had it to their right.

A woman explains how pushing her anxiety aside to care for her sister with cancer was not good for her own health. “I wondered about all the other caregivers out there. I wondered if they, too, were suffering in silence because they did not want to draw focus away from the person they were caring for,” she writes.

A woman describes how caring for her mother, who has stage 4 metastatic breast cancer, drastically changed her life and her priorities.

Patients and caregivers of those with kidney cancer can become active members in their care by staying up to date on the latest treatments and medical advances.

Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.

People without cancer may not understand the guilt survivors feel when their disease improves and others take a turn for the worse.

Exposure to certain high blood pressure drugs, specifically thiazide diuretics, may increase a person’s risk of developing skin cancer.

A mother and cancer caregiver expresses her frustration over the lack of breast cancer screening in young women and explains how catching cancer early saved her daughter’s life.

The average survival for patients with malignant pleural mesothelioma was less than a month after being diagnosed with COVID-19, according to a small study.

Patients with blood cancer who underwent stem cell transplant and developed chronic graft-versus-host disease have more treatment options than ever before. But the formula for planning older and newer therapies has not yet been established.

A 13-time cancer survivor shares his complex, long and frustrating cancer journey, and explains how he is able to keep hope alive.

A colleague describes a fellow oncology nurse who welcomes everyone who walks through their doors and makes every effort to make patients feel as comfortable as possible.

The novel drug N-803 boosted response to Bacille Calmette-Guérin therapy in patients with non-muscle invasive bladder cancer, a study showed.

During anxious times throughout treatment, one patient details how her oncology nurse helped her to relax at visits to her cancer center.

Despite a testicular cancer diagnosis, men have options when it comes to starting or growing their family.